Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Assoc. Prof. Dr. Carmen Berenguer | Universitat de Valencia | Spain

Dr. Carmen Berenguer is an Associate Professor in the Department of Developmental and Educational Psychology at the University of Valencia. She holds a degree in Psychology, a Master’s in Cognitive Neuroscience and Special Educational Needs, and a Ph.D. in Psychology with the distinction of Cum Laude and International Doctorate from the same university. Her research has consistently focused on neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD), exploring cognitive, social, communication, and learning dimensions. In recent years, she has extended her work to examine comorbid conditions such as sleep difficulties and to design psychosocial intervention programs for families of children with ASD and ADHD. Dr. Berenguer has completed or participated in nine research projects and authored 20 books. She holds two patents related to psychosocial programs and augmented reality applications for educational and therapeutic purposes. With 54 published documents, her work has been cited in 994 scientific papers, accumulating a total of 1,077 citations and achieving an h-index of 17, reflecting her significant impact in developmental psychology and neurodevelopmental research.

Profiles: Scopus | orcid | Google Scholar

Featured Publications

(2025). Characteristics, motivations and attitudes of students using ChatGPT and other language model-based chatbots in higher education. Education and Information Technologies.

(2025). Parenting stress in autistic and ADHD children: Implications of social support and child characteristics. Journal of Autism and Developmental Disorders.

(2025). Sleep disturbances in autistic children and adolescents: A systematic review and meta-analysis of randomized controlled trials.

(2025). Augmented reality and learning-cognitive outcomes in autism spectrum disorder: A systematic review.

(2025). Occupational stress, burnout, and job satisfaction amongst Spanish speech-language pathologists. International Journal of Speech Language Pathology.

William Blumentals | Clinical Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Dr. William Blumentals | Clinical Neuroscience | Excellence in Research Award

Dr. William Blumentals | Sanofi | United States

Dr. William A. Blumentals is an accomplished epidemiologist and pharmaceutical executive recognized for his leadership in pharmacoepidemiology, real-world evidence generation, and global health outcomes research. He serves as Associate Vice President and Head of Specialty Care Pharmacoepidemiology at Sanofi in Cambridge, Massachusetts, where he oversees a multinational team of epidemiologists across the United States and Europe, driving innovation in inflammation, immunology, oncology, and rare disease research. With a Ph.D. in Epidemiology from the University of South Florida, along with advanced degrees in Statistics, Epidemiology, and Biology, Dr. Blumentals has held senior positions at leading organizations including Shire Pharmaceuticals, Shionogi Inc., and Hoffmann-La Roche. His expertise spans strategic development of large-scale observational studies, organizational leadership, and cross-functional collaboration to optimize evidence-based decision-making in healthcare. As a thought leader in real-world evidence and outcomes research, he has contributed significantly to advancing global epidemiological practices. Dr. Blumentals has authored 36 scientific documents, accumulated 1,594 citations from 1,463 documents, and holds an h-index of 23, reflecting his strong scientific influence and impact in epidemiology and pharmaceutical research.

Profile: Scopus

Featured Publications

Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. (2025). Multiple Sclerosis and Related Disorders.


Cytokine release syndrome risk model with T-cell engaging therapies. (2025). Cytotherapy.


Evaluating the accuracy of responses by large language models for information on disease epidemiology. (2025). Pharmacoepidemiology and Drug Safety.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Calixto Machado | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Calixto Machado | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Calixto Machado | Institute of Neurology and Neurosurgery | Cuba

Calixto Machado is a Full Professor and Senior Researcher in Neurology and Clinical Neurophysiology at the Institute of Neurology and Neurosurgery in Havana, Cuba, and a Corresponding Fellow of the American Academy of Neurology. He completed his medical degree, followed by specialist training in neurology and clinical neurophysiology, and then earned his PhD. Over four decades he has led pioneering research on disorders of consciousness, brain death, stroke, autism, autonomic nervous system disorders and the neurological sequelae of SARS-CoV-2. He has published nearly 700 peer-reviewed journal articles, book chapters and authored seven books; his work is recognised internationally through numerous symposia and awards. His Google Scholar profile lists an h-index of 37, and over 24 000 citations across his published documents.

Profile: Google Scholar

Featured Publications:

Machado, C. (2025, September 9). Jahi McMath case: A comprehensive and updated narrative. World Journal of Critical Care Medicine, 14(3), 107513.

Machado, C. (2022). The Jahi McMath case: First detailed study of her brain. Neurology India, 70(5), 22–35.

Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., Kelly, J. P., & others. (2002). The minimally conscious state: Definition and diagnostic criteria. Neurology, 58(3), 349–353.

Sloan, M. A., Alexandrov, A. V., Tegeler, C. H., Spencer, M. P., Caplan, L. R., & others. (2004). Assessment: Transcranial Doppler ultrasonography report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 62(9), 1468–1481.

Machado, C. (2002). Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology.

Machado, C. (2007). Cerebral response to patient’s own name in the vegetative and minimally conscious states. Neurology, 69(7), 708.

Machado, C., Korein, J., Ferrer, Y., Portela, L., & others. (2007). The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics, 33, 197–200.

Machado, C. (2007). The concept of brain death did not evolve to benefit organ transplants. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2007). Brain death: A reappraisal. Springer Science & Business Media.

Machado, C. (2007). The first organ transplant from a brain-dead donor. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2010). Diagnosis of brain death. Neurology International, 2(1), e2.

Graf, W. D., Miller, G., Epstein, L. G., & Rapin, I. (2017). The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology, 88(14), 1371–1380.

Machado, C., Korein, J., Aubert, E., Bosch, J., Alvarez, M. A., Rodríguez, R., & others. (2007). Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience, 38(3), 124–126.

Lewis, A., Bernat, J. L., Blosser, S., Bonnie, R. J., Epstein, L. G., Hutchins, J., & others. (2018). An interdisciplinary response to contemporary concerns about brain death determination. Neurology, 90(9), 423–426.*

Siphokazi Gatyeni | Systems Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Siphokazi Gatyeni | Systems Neuroscience | Best Researcher Award

Dr. Siphokazi Gatyeni | University of Johannesburg | South Africa

Dr Siphokazi Princess Gatyeni is a Lecturer in the Department of Mathematics and Applied Mathematics at the University of Johannesburg, having progressed through roles as Assistant Lecturer and Marker. She earned her PhD in Applied Mathematics with a thesis on the long-term dynamics of COVID-19 in South Africa under the supervision of Prof Farai Nyabadza and Prof Faraimunashe Chirove. Prior to that she completed an MSc in Mathematics studying modelling of in- and out-patient rehabilitation for substance abuse, and an Honours in Biomathematics modelling substance abuse dynamics. Her research focuses on infectious-disease modelling (COVID-19, TB, malaria), optimal control theory and social behaviour in epidemic systems, with demonstrated expertise in MATLAB, Python, Mathematica, LaTeX, R-Studio, Excel and SPSS. According to Google Scholar she has been cited 41 times. Her h-index is currently not publicly listed on that profile but the citation count reflects an active early-career research trajectory. Her work includes recent journal articles on meningitis transmission and the impact of vaccination strategies, as well as modelling the effects of stigma on COVID-19 transmission. In the classroom she emphasises real-world applications and technology-assisted instruction, teaching courses from Engineering Mathematics through Numerical Analysis and Special Topics, and is committed to mentoring postgraduate students in interdisciplinary mathematical modelling.

Profile: orcid

Featured Publications

Gatyeni, S. P. (2025). Mathematical modeling of meningitis transmission dynamics and the impact of vaccination strategies. Scientific African, e03048.

Mbalilo, V. M., Nyabadza, F., & Gatyeni, S. P. (2025). Modelling the potential impact of TB-funded prevention programs on the transmission dynamics of TB. Infectious Disease Modelling.

Gatyeni, S. P., Chirove, F., & Nyabadza, F. (2022). Modelling the potential impact of stigma on the transmission dynamics of COVID-19 in South Africa. Mathematics, 10(18), 3253.

Gatyeni, S. P. (2022). Application of optimal control to the dynamics of COVID-19 disease in South Africa. Scientific African, e01268.

Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Dr. Seyyed Ali | Zendehbad University of Mazandaran | Iran

Dr. Seyyed Ali Zendehbad is a multidisciplinary researcher specializing in biomedical signal processing, cognitive computational neuroscience, and neurorehabilitation technologies. His research integrates deep learning, pattern recognition, and multimodal biological data modeling to enhance fatigue detection and neurorehabilitation systems. He has authored several peer-reviewed papers in reputable journals such as Scientific Reports, IEEE Access, Sensing and Bio-Sensing Research, and Healthcare Technology Letters, focusing on hybrid AI frameworks, EMG signal processing, and muscle synergy-based biofeedback mechanisms. Dr. Zendehbad’s work on developing intelligent rehabilitation systems, including his models like TraxVBF and FatigueNet, contributes to advancing telemonitoring and assistive technologies for neurological recovery. His scholarly output includes more than 25 documents, over 600 citations, and an h-index of 12, reflecting his growing impact in computational neuroscience and biomedical engineering. Recognized for innovation, he has achieved first-place awards in multiple national startup competitions and was honored with the Best Poster Award at the Congress of Neurology and Clinical Electrophysiology of Iran. As a postdoctoral researcher at the University of Mazandaran, his ongoing work emphasizes integrating trustworthy AI into telehealth systems, promoting equitable and efficient digital healthcare delivery through interdisciplinary research and technological innovation.

Profile: Orcid

Featured Publications

1. Mazrooei Rad, E., Mazinani, S. M., & Zendehbad, S. A. (2025). Diagnosis of Alzheimer’s disease using non-linear features of ERP signals through a hybrid attention-based CNN-LSTM model. Computer Methods and Programs in Biomedicine Update, 5, 100192.

2. Zendehbad, S. A., Sharifi Razavi, A., Tabrizi, N., & Sedaghat, Z. (2025). A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective. Epilepsy Research, 207, 107582.

3. Mazrooei Rad, E., Zendehbad, S. A., & Hosseinzadeh, V. (2025). Fetal QRS complex detection based on adaptive filters and peak detection. Research on Biomedical Engineering, 41(3), 424–438.

4. Zendehbad, S. A., Ghasemi, J., & Samsami Khodadad, F. (2025). FatigueNet: A hybrid graph neural network and transformer framework for real-time multimodal fatigue detection. Scientific Reports, 15(1), 640.

5. Safdel, A., Zendehbad, S. A., & Ghasemi, J. (2025). Advanced deep learning approaches for accurate and efficient suspicious behavior detection in surveillance videos. Computational Sciences and Engineering, 21(2), 1099.

Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | University of Tokyo | Japan

Dr. Tatsuya Yamasoba is a Professor Emeritus at the University of Tokyo and Director of Tokyo Teishin Hospital, recognized internationally for his contributions to otology, neurotology, laryngology, and clinical neuroscience. He has published over 500 scientific papers in leading journals such as Science, Nature Chemistry, Nature Nanotechnology, Neuron, PNAS, and Neurology. His research focuses on regenerative medicine for sensorineural hearing loss, vestibular dysfunction, and dysphagia management in neurodegenerative diseases. With a citation index of over 24,150, an h-index of 75, and an i10-index of 353, his work has significantly advanced understanding and treatment of auditory and balance disorders. He has developed surgical techniques for severe hearing loss, pioneered galvanic vestibular stimulation therapy for disequilibrium, and improved aspiration prevention surgeries. Dr. Yamasoba has served as Editor-in-Chief of Auris Nasus Larynx and Associate Editor for ORL Journal and npj Aging and Mechanisms of Disease. He collaborates with leading research institutions including the University of Michigan and the University of California, Davis. His professional memberships include the International Federation of ORL Societies and the Asia Oceania Otorhinolaryngology and Head and Neck Society, reflecting his leadership and influence in advancing otolaryngology and auditory neuroscience globally.

Profile: Google Scholar

Featured Publications

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., et al. (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309(5733), 481–484.

Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., et al. (2015). Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC study. Allergy, 70(8), 995–1003.

Yamasoba, T., Lin, F. R., Someya, S., Kashio, A., Sakamoto, T., & Kondo, K. (2013). Current concepts in age-related hearing loss: Epidemiology and mechanistic pathways. Hearing Research, 303, 30–38.

Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., & Miller, J. M. (2007). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.

Umezawa, K., Yoshida, M., Kamiya, M., Yamasoba, T., & Urano, Y. (2017). Rational design of reversible fluorescent probes for live-cell imaging and quantification of fast glutathione dynamics. Nature Chemistry, 9(3), 279–286.

Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., et al. (2016). Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nature Nanotechnology, 11(6), 533–538.

Iwasaki, S., & Yamasoba, T. (2014). Dizziness and imbalance in the elderly: Age-related decline in the vestibular system. Aging and Disease, 6(1), 38–47.

Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., et al. (2009). Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences, 106(46), 19432–19437.

Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jane Paulsen | University of Wisconsin Madison | United States

Dr. Jane S. Paulsen, Ph.D., is a Professor of Neurology and Vice Chair for Research at the University of Wisconsin–Madison, where she also contributes to the Department of Neurosciences Graduate Program. Her expertise lies in cognitive, psychiatric, and imaging correlates of neuropsychiatric disorders, with a strong focus on the early detection of brain diseases and the development of innovative methods for clinical trials. She has significantly advanced the understanding of genetic discrimination and the discovery and validation of biological and clinical markers of brain disease, incorporating neuroimaging and omics-based outcomes into her research. Dr. Paulsen completed her Ph.D. in Counseling Psychology at the University of Iowa, followed by postdoctoral training in Neuropsychology at the University of California, San Diego, where she worked on Alzheimer’s and geriatric psychiatry research. Over her career, she has held key positions including Director of the Huntington’s Disease Clinical Research Program at UCSD and has contributed extensively to advancing neuropsychological research and clinical applications. Her scholarly impact includes 4 published documents, 78 citations from 77 documents, and an h-index of 3, reflecting her influence in the fields of neurology, neuropsychology, and cognitive neuroscience.

Profiles: Scopus | Google Scholar | Reserach Gate | linked In

Featured Publications

Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014). Classifying neurocognitive disorders: The DSM-5 approach. Nature Reviews Neurology, 10(11), 634–642.

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216.

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., & Shoulson, I. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880.

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & International Huntington’s Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277.

Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., & Paulsen, J. S. (1998). Apathy is not depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 314–319.

Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., & Paulsen, J. S. (2014). Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Disease & Associated Disorders, 28(3), 206–218.

Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., & Zisook, S. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11(3), 437–446.

Plis, S. M., Hjelm, D. R., Salakhutdinov, R., Allen, E. A., Bockholt, H. J., Long, J. D., & Calhoun, V. D. (2014). Deep learning for neuroimaging: A validation study. Frontiers in Neuroscience, 8, 229.

Mohamed, S., Paulsen, J. S., O’Leary, D., Arndt, S., & Andreasen, N. (1999). Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56(8), 749–754.

Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S., & Cummings, J. L. (2001). Neuropsychiatric aspects of Huntington’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 71(3), 310–314.

Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil |  National Research Centre | Egypt

Dr. Wagdy Khalil is a Professor of Animal Genetics specializing in Molecular Genetics at the Cell Biology Department, National Research Centre, Egypt. His research focuses on genetic and molecular mechanisms underlying animal reproduction, gene expression, and environmental genotoxicity. He has significantly contributed to the understanding of oocyte maturation, preovulatory hormonal regulation, and molecular responses to toxins, nanoparticles, and natural therapeutic agents. Dr. Khalil’s work integrates molecular biology, biotechnology, and animal genetics to explore the genetic basis of fertility, mutagenicity, and disease resistance. He has published 161 scientific papers in peer-reviewed journals indexed in Scopus, reflecting his consistent research productivity and international collaboration. His studies have advanced knowledge in fields such as reproductive biology, toxicogenomics, molecular diagnostics, and genetic engineering. Dr. Khalil’s impactful research has earned him 2,055 citations from 1,801 documents, demonstrating wide recognition within the scientific community. With an h-index of 27, his work continues to influence emerging research in molecular genetics and biotechnology, bridging fundamental discoveries with applied biomedical and agricultural innovations.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

  • Antiarthritic activities of berberine in a rat model of gouty arthritis. (2025). Scientific Reports.

  • Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. (2025). Scientific Reports.

  • Comparative study of pyridine and pyrimidine derivatives as promising anti-inflammatory agents: Design, synthesis, and LPS-induced RAW 264.7 macrophages. (2025). Drug Development Research.

  • Expression of growth factors in buffalo ovarian tissue across different follicular developmental stages. (2025). Archives of Gynecology and Obstetrics.

  • Estrus, preovulatory LH surge and oocyte maturation in Goettingen miniature pigs (Sus scrofa domesticus). (2025). Theriogenology.

  • Targeting apoptotic pathways in cancer: Design, synthesis, and molecular docking studies of 1,3,5-trisubstituted-1H-pyrazole derivatives with Bcl-2 inhibition and DNA damage potential. (2025). RSC Advances.

  • Assessment of the gold nanoparticles biosynthesized using Casuarina equisetifolia bark extract against the ethion-induced hepato- and neurotoxicity in rats. (2025). Journal of Genetic Engineering and Biotechnology.

  • In vitro and in vivo antidiabetic evaluation of new coumarin and chromone derivatives: Design, synthesis, and molecular modeling. (2025). Bioorganic Chemistry.

  • Potential therapeutic effects of interleukin-1 receptor type 1 antagonist and the ethyl acetate fraction of Murraya exotica leaves against κ-carrageenan-induced vein thrombosis in rats. (2025). Phytomedicine Plus.

  • The ability of stressor factors of environmental pollution to induce ROS and 8-OHdG mediated apoptosis in fish species of Suez Gulf, Red Sea. (2025). Egyptian Journal of Chemistry.

Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Dr. Eleni Tsakiri |  National and Kapodistrian University of Athens Medical School | Greece

Dr. Eleni Tsakiri is a distinguished Molecular Biologist whose research centers on the molecular mechanisms of aging, proteostasis, and neurodegeneration. She earned her Ph.D. in Biology from the National and Kapodistrian University of Athens (NKUA) with a thesis on proteome homeostasis and its alterations during aging, following her M.Sc. in Cell Biology and Biophysics and a B.Sc. in Molecular Biology and Genetics. Dr. Tsakiri has held multiple postdoctoral positions at leading Greek institutions, including the Medical School of NKUA and the Biomedical Research Center “Alexander Fleming,” where she contributed to projects on proteasome regulation, Tau aggregation, and ribosome-mediated cell competition. Currently, she serves as a Postdoctoral Researcher at the Laboratory of Physiology, NKUA, focusing on neurodegeneration and aging under an ERC-funded project. Her research is supported by competitive grants such as the Hellenic Foundation for Research and Innovation (HFRI). She has supervised undergraduate, master’s, and doctoral students and actively collaborates with prominent researchers in Greece and abroad. Dr. Tsakiri’s contributions are reflected in her 24 published documents, 730 citations, and an h-index of 15, highlighting her impact in molecular biology and aging research.

Profiles: Scopus | Google Scholar | Research Gate | LInked In

Featured Publications

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Terpos, E., Dimopoulos, M. A., & others. (2013). Proteasome dysfunction in Drosophila signals to an Nrf2‐dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell, 12(5), 802–813.

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Gorgoulis, V. G., Bohmann, D., & others. (2013). Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress. The FASEB Journal, 27(6), 2407–2419.

  • Tsakiri, E. N., & Trougakos, I. P. (2015). The amazing ubiquitin-proteasome system: Structural components and implication in aging. International Review of Cell and Molecular Biology, 314, 171–237.

  • Tsakiri, E. N., Iliaki, K. K., Höhn, A., Grimm, S., Papassideri, I. S., & Grune, T. (2013). Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Free Radical Biology and Medicine, 65, 1155–1163.

  • Tsakiri, E. N., Gumeni, S., Iliaki, K. K., Benaki, D., Vougas, K., Sykiotis, G. P., et al. (2019). Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation. Aging Cell, 18(1), e12845.